Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
11450420 | September 20, 2022 | ||||||||
Patent 7209075 was granted and assigned to Pfizer on April, 2007 by the United States Patent and Trademark Office. | 7209075 | April 24, 2007 | |||||||
Patent 7030242 was granted and assigned to Pfizer on April, 2006 by the United States Patent and Trademark Office. | 7030242 | April 18, 2006 | |||||||
Patent 11400052 was granted and assigned to Jazz Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office. | 11400052 | August 2, 2022 | |||||||
Patent 6894041 was granted and assigned to Pfizer on May, 2005 by the United States Patent and Trademark Office. | 6894041 | May 17, 2005 | |||||||
Patent 6849629 was granted and assigned to Pfizer on February, 2005 by the United States Patent and Trademark Office. | 6849629 | February 1, 2005 | |||||||
Patent 7232680 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office. | 7232680 | June 19, 2007 | |||||||
Patent 7132106 was granted and assigned to Pfizer on November, 2006 by the United States Patent and Trademark Office. | 7132106 | November 7, 2006 | |||||||
Patent 10080851 was granted and assigned to Syqe on September, 2018 by the United States Patent and Trademark Office. | 10080851 | September 25, 2018 | |||||||
Patent 7405226 was granted and assigned to Pfizer on July, 2008 by the United States Patent and Trademark Office. | 7405226 | July 29, 2008 | |||||||
Patent 12023665 was granted and assigned to Pfizer on July, 2024 by the United States Patent and Trademark Office. | 12023665 | July 2, 2024 | |||||||
Patent 10912754 was granted and assigned to Jazz Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office. | 10912754 | February 9, 2021 | |||||||
Patent 10940133 was granted and assigned to Jazz Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office. | 10940133 | March 9, 2021 | |||||||
Patent 9775379 was granted and assigned to Syqe on October, 2017 by the United States Patent and Trademark Office. | 9775379 | October 3, 2017 | |||||||
Patent 7118885 was granted and assigned to Pfizer on October, 2006 by the United States Patent and Trademark Office. | 7118885 | October 10, 2006 | |||||||
Patent 9050302 was granted and assigned to Jazz Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office. | 9050302 | June 9, 2015 | |||||||
Patent 10213400 was granted and assigned to Jazz Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office. | 10213400 | February 26, 2019 | |||||||
Patent 10959976 was granted and assigned to Jazz Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office. | 10959976 | March 30, 2021 | |||||||
Patent 11311480 was granted and assigned to Syqe on April, 2022 by the United States Patent and Trademark Office. | 11311480 | April 26, 2022 | |||||||
Patent 9486426 was granted and assigned to Jazz Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office. | 9486426 | November 8, 2016 | |||||||
Patent 7387623 was granted and assigned to Pfizer on June, 2008 by the United States Patent and Trademark Office. | 7387623 | June 17, 2008 | |||||||
Patent 10918633 was granted and assigned to MyMD Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office. | 10918633 | February 16, 2021 | |||||||
Patent 7231074 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office. | 7231074 | June 12, 2007 | |||||||
Patent 11229758 was granted and assigned to Syqe on January, 2022 by the United States Patent and Trademark Office. | 11229758 | January 25, 2022 | |||||||
Patent 8952029 was granted and assigned to Jazz Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office. | 8952029 | February 10, 2015 |